CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases ( vol 65 , pg 1157 , 2022)

被引：0
|
作者：
Xue, Bai [1 ]
Wang, Ping [2 ]
Yu, Wenzhen [3 ]
Feng, Jing [2 ]
Li, Jie [4 ]
Zhao, Rulian [1 ]
Yan, Zhenglin [1 ,5 ]
Yan, Xiyun [2 ,6 ,7 ]
Duan, Hongxia [2 ]
机构：
[1] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Peoples R China
[2] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100101, Peoples R China
[3] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100044, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Ophthalmol, Chengdu 610072, Peoples R China
[5] Chinese Acad Med Sci 2019RU026, Res Unit Blindness Prevent, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Chengdu 610072, Peoples R China
[6] Zhengzhou Univ, Nanozyme Med Ctr, Sch Basic Med Sci, Zhengzhou 450001, Peoples R China
[7] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China
来源：
SCIENCE CHINA-LIFE SCIENCES | 2024年 / 67卷 / 02期
关键词：
D O I：
10.1007/s11427-023-2427-x
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：434 / 434
页数：1
相关论文
共 7 条
  • [1] CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases
    Xue, Bai
    Wang, Ping
    Yu, Wenzhen
    Feng, Jing
    Li, Jie
    Zhao, Rulian
    Yang, Zhenglin
    Yan, Xiyun
    Duan, Hongxia
    SCIENCE CHINA-LIFE SCIENCES, 2022, 65 (06) : 1157 - 1170
  • [2] CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases
    Bai Xue
    Ping Wang
    Wenzhen Yu
    Jing Feng
    Jie Li
    Rulian Zhao
    Zhenglin Yang
    Xiyun Yan
    Hongxia Duan
    Science China Life Sciences, 2022, 65 (06) : 1157 - 1170
  • [3] CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases
    Bai Xue
    Ping Wang
    Wenzhen Yu
    Jing Feng
    Jie Li
    Rulian Zhao
    Zhenglin Yang
    Xiyun Yan
    Hongxia Duan
    Science China Life Sciences, 2022, 65 : 1157 - 1170
  • [4] Erratum to: CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases
    Bai Xue
    Ping Wang
    Wenzhen Yu
    Jing Feng
    Jie Li
    Rulian Zhao
    Zhenglin Yan
    Xiyun Yan
    Hongxia Duan
    Science China Life Sciences, 2024, 67 : 434 - 434
  • [5] Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells (vol 16, pg 5165, 2010)
    Ma, Xiaoli
    Liu, Jia
    Wu, Jiang
    Yan, Xiyun
    Wu, Peng
    Liu, Yong
    Li, Shuang
    Tian, Yuan
    Cao, Yang
    Chen, Gang
    Meng, Li
    Xu, Gang
    Wang, Shixuan
    Lu, Yunping
    Ma, Ding
    Zhou, Jianfeng
    CLINICAL CANCER RESEARCH, 2022, 28 (20) : 4589 - 4589
  • [6] Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells (Expression of Concern of Vol 16, Pg 5165, 2010)
    Ma, Xiaoli
    Liu, Jia
    Wu, Jiang
    Yan, Xiyun
    Wu, Peng
    Liu, Yong
    Li, Shuang
    Tian, Yuan
    Cao, Yang
    Chen, Gang
    Meng, Li
    Xu, Gang
    Wang, Shixuan
    Lu, Yunping
    Ma, Ding
    Zhou, Jianfeng
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1530 - 1530
  • [7] Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells (Publication with Expression of Concern. See vol. 26, pg. 1530, 2020)
    Ma, Xiaoli
    Liu, Jia
    Wu, Jiang
    Yan, Xiyun
    Wu, Peng
    Liu, Yong
    Li, Shuang
    Tian, Yuan
    Cao, Yang
    Chen, Gang
    Meng, Li
    Xu, Gang
    Wang, Shixuan
    Lu, Yunping
    Ma, Ding
    Zhou, Jianfeng
    CLINICAL CANCER RESEARCH, 2010, 16 (21) : 5165 - 5176
1